2002
================================================================================

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

------------------

FORM 10-Q

(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2002.

[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ____________ to _________________

Commission File No. 000-24657

MANNATECH, INCORPORATED
(Exact Name of Registrant as Specified in its Charter)

Texas 75-2508900
(State or other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)

600 S. Royal Lane, Suite 200
Coppell, Texas
75019

(Address of Principal Executive Offices, including Zip Code)

Registrant's Telephone Number, including Area Code: (972) 471-7400

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No ___.
---
As of May 14, 2002, the number of shares outstanding of the registrant's
sole class of common stock, par value $0.0001 per share was 25,134,840.

TABLE OF CONTENTS

Page
----

Part I - FINANCIAL INFORMATION

Item 1. Financial Statements.......................................................................... 1
Consolidated Balance Sheets........................................................................ 1
Consolidated Statements of Operations.............................................................. 2
Consolidated Statements of Cash Flows.............................................................. 3
Notes to Consolidated Financial Statements......................................................... 4

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations......... 7
Overview........................................................................................... 7
Results of Operations.............................................................................. 10
Three months ended March 31, 2002 compared with the three months ended
March 31, 2001................................................................................. 10
Liquidity and Capital Resources.................................................................... 12
Recent Financial Accounting Standards Board Statements............................................. 14
Outlook............................................................................................ 15
Forward-looking Statements......................................................................... 15

Item 3. Quantitative and Qualitative Disclosures About Market Risk................................... 16

Part II - OTHER INFORMATION

Item 1. Legal Proceedings............................................................................ 17
Item 2. Changes in Securities and Use of Proceeds ................................................... 17
Item 3. Defaults Upon Senior Securities.............................................................. 17
Item 4. Submission of Matters to a Vote of Security Holders.......................................... 17
Item 5. Other Information............................................................................ 17
Item 6. Exhibits and Reports on Form 8-K............................................................. 17
Signatures............................................................................................ 18

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

MANNATECH, INCORPORATED
CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)

December 31, March 31,
2001 2002
---- ----
(Unaudited)

ASSETS

Cash and cash equivalents ................................................................. $ 9,926 $ 12,734
Accounts receivable ....................................................................... 613 1,546
Current portion of notes receivable-shareholders .......................................... 119 174
Inventories ............................................................................... 8,386 5,937
Prepaid expenses and other current assets ................................................. 1,064 1,180
Deferred tax assets ....................................................................... 1,535 1,536
-------- --------
Total current assets .............................................................. 21,643 23,107
Property and equipment, net ............................................................... 10,448 9,745
Notes receivable-shareholders, excluding current portion .................................. 334 229
Restricted cash ........................................................................... -- 300
Other assets .............................................................................. 718 671
-------- --------
Total assets ...................................................................... $ 33,143 $ 34,052
======== ========

LIABILITIES AND SHAREHOLDERS' EQUITY

Current portion of capital leases and notes payable ....................................... $ 315 $ 301
Accounts payable .......................................................................... 509 425
Accrued expenses .......................................................................... 13,165 14,065
Current portion of accrued severance ...................................................... 1,732 1,621
-------- --------
Total current liabilities ......................................................... 15,721 16,412
Capital leases and notes payable, excluding current portion ............................... -- 15
Accrued severance, excluding current portion .............................................. 950 625
Deferred tax liabilities .................................................................. 380 382
-------- --------
Total liabilities ................................................................. 17,051 17,434
-------- --------
Commitments and contingencies (Note 4) .................................................... -- --

Shareholders' equity:
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued and
outstanding ........................................................................... -- --
Common stock, $0.0001 par value, 99,000,000 shares authorized, 25,162,541 shares issued
and 25,134,840 outstanding in 2001 and 2002 ........................................... 3 3
Additional paid-in capital ................................................................ 18,204 18,191
Accumulated deficit ....................................................................... (1,407) (811)
Accumulated other comprehensive loss--foreign currency translation adjustment ............. (608) (665)
-------- --------
16,192 16,718
Less treasury stock, at cost, 27,701 shares in 2001 and 2002 .............................. (100) (100)
-------- --------
Total shareholders' equity ........................................................ 16,092 16,618
-------- --------
Total liabilities and shareholders' equity ........................................ $ 33,143 $ 34,052
======== ========

See accompanying notes to consolidated financial statements.

MANNATECH, INCORPORATED
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR THE THREE MONTHS ENDED MARCH 31, 2001 AND 2002
(in thousands, except per share information)

Three months ended
March 31,
----------------------
2001 2002
-------- --------

Net Sales .......................................... $ 34,195 $ 32,926
-------- --------

Cost of Sales ...................................... 5,726 5,903
Commissions ........................................ 13,805 13,821
-------- --------
19,531 19,724
-------- --------
Gross profit .................................. 14,664 13,202
-------- --------

Operating Expenses:
Selling and administrative expenses ........... 9,034 7,502
Other operating costs ......................... 6,124 4,536
-------- --------
Total operating expenses .................. 15,158 12,038
-------- --------

Income (loss) from operations ...................... (494) 1,164

Interest income .................................... 97 74
Interest expense ................................... (9) (6)
Other expense, net ................................. (115) (17)
-------- --------
Income (loss) before income taxes .................. (521) 1,215
Income tax (expense) benefit ....................... 212 (619)
-------- --------

Net income (loss) .................................. $ (309) $ 596
======== ========

Earnings (loss) per common share:

Basic ......................................... $ (0.01) $ 0.02
======== ========
Diluted ....................................... $ (0.01) $ 0.02
======== ========

Weighted-average common shares outstanding:

Basic ......................................... 24,799 25,135
======== ========
Diluted ....................................... 24,799 25,269
======== ========

See accompanying notes to consolidated financial statements.

MANNATECH, INCORPORATED
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE THREE MONTHS ENDED MARCH 31, 2001 AND 2002
(in thousands)

2001 2002
-------- --------

Cash flows from operating activities:
Net income (loss) ....................................................................... $ (309) $ 596
Adjustments to reconcile net income (loss) to net cash provided by (used in)
operating activities:
Depreciation and amortization ......................................................... 991 994
(Gain) loss on disposal of assets ..................................................... (12) 21
Accounting charge related to stock options granted .................................... -- (13)
Deferred income taxes ................................................................. -- 1
Changes in operating assets and liabilities:
Accounts receivable ................................................................. 72 (935)
Inventories ......................................................................... (118) 2,445
Prepaid expenses and other current assets ........................................... 21 (117)
Other assets ........................................................................ 69 44
Accounts payable .................................................................... (1,169) (82)
Accrued expenses .................................................................... 55 903
Accrued severance ................................................................... -- (436)
-------- --------
Net cash provided by (used in) operating activities ............................. (400) 3,421
-------- --------

Cash flows from investing activities:
Acquisition of property and equipment ................................................. (73) (288)
Cash proceeds from sale of property and equipment ..................................... 2 --
Repayments by shareholders/related parties ............................................ 143 50
Increase in restricted cash ........................................................... -- (300)
Maturities of investments ............................................................. 1 --
-------- --------
Net cash provided by (used in) investing activities ............................. 73 (538)
-------- --------

Cash flows from financing activities:

Book overdrafts ....................................................................... (1,352) --
Repayment of capital lease obligations ................................................ (146) (14)
Purchase of common stock from shareholder ............................................. (83) --
Repayment of notes payable ............................................................ (16) (18)
-------- --------
Net cash used in financing activities ........................................... (1,597) (32)
-------- --------

Effect of exchange rate changes on cash and cash equivalents ............................ (6) (43)
-------- --------

Net increase (decrease) in cash and cash equivalents .................................... (1,930) 2,808
Cash and cash equivalents:
Beginning of the period ............................................................... 5,736 9,926
-------- --------
End of the period ..................................................................... $ 3,806 $ 12,734
======== ========

Supplemental disclosure of cash flow information:
Interest paid ......................................................................... $ 9 $ 6
======== ========
Taxes paid ............................................................................ $ -- $ 1,200
======== ========

Summary of non-cash investing and financing activities follows:
Assets acquired through notes payable and a capital lease ............................ $ 187 $ 33
======== ========
Treasury shares received for the payment of a note receivable due from a shareholder... $ 167 $ --
======== ========

See accompanying notes to consolidated financial statements.

MANNATECH, INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1 ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Mannatech, Incorporated (the "Company") was incorporated in the State of
Texas on November 4, 1993, as Emprise International, Inc. Effective October 25,
1995, the Company changed its name to Mannatech, Incorporated. The Company,
located in Coppell, Texas, develops and sells high-quality, proprietary
nutritional supplements, topical products and weight-management products
primarily through a network marketing system operating in the United States,
Canada, Australia, the United Kingdom and Japan. Independent associates
("associates") purchase the Company's products at wholesale prices for the
primary purpose of selling to retail consumers or for personal consumption,
while independent members ("members") purchase products at a discount from
retail prices. Associates are eligible to earn commissions on their downline
growth and sales volume. The Company has nine wholly-owned subsidiaries located
throughout the world. The wholly-owned subsidiaries are as follows:

Wholly-owned subsidiary name Date incorporated Location of subsidiary Date operations began
---------------------------- ----------------- ---------------------- ---------------------

Mannatech Australia Pty Limited April 22, 1998 St. Leonards, Australia October 1, 1998
Mannatech Limited December 1, 1998 Republic of Ireland No operations
Mannatech Ltd. November 18, 1998 Aldermaston, Berkshire November 15, 1999
U.K.
Mannatech Payment Services Incorporated April 11, 2000 Coppell, Texas June 26, 2000
Mannatech Foreign Sales Corporation* May 1, 1999 Barbados May 1, 1999
Internet Health Group, Inc. * May 7, 1999 Coppell, Texas December 20, 1999
Mannatech Japan, Inc. January 21, 2000 Tokyo, Japan June 26, 2000
Mannatech Limited February 14, 2000 New Zealand No operations
Mannatech Products Company, Inc. April 17, 2001 Coppell, Texas No operations

-------------------------------------------
*Subsidiaries ceased operations on December 29, 2000.

The accompanying unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Rule 10-01 of
Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of Company's management, the accompanying
unaudited consolidated financial statements contain all adjustments, consisting
of normal recurring adjustments, considered necessary for a fair statement of
the Company's financial information as of, and for, the periods presented. The
consolidated results of operations of any interim period are not necessarily
indicative of the consolidated results of operations to be expected for the
fiscal year. For further information, refer to the Company's consolidated
financial statements and accompanying footnotes included in the Company's annual
report on Form 10-K for the year ended December 31, 2001.

Principles of Consolidation

The consolidated financial statements include the accounts of the
Company and its wholly-owned subsidiaries. All significant intercompany balances
and transactions have been eliminated in consolidation.

Revenue Recognition

The Company's revenues consist of sales from products sold, starter and
renewal packs sold and shipping fees charged. Substantially all product sales
are sold to associates at published wholesale prices and are sold to members at
a discount from retail prices. The Company also records a product return reserve
related to refunds in net sales. The Company records the product return reserve
based on historical experience in net sales.

The Company defers all of its revenues until the associate or member
receives the shipment. The Company also defers a portion of the revenue received
from the sale of the starter and renewal packs when the revenue exceeds the
excess of the total average wholesale value of all of the individual items
included in such packs and amortizes such deferrals over a twelve-month period.
Some of the higher dollar packs also contain an event admission pass, which
allows an associate free admission to a corporate sponsored event. Revenues from
these packs are allocated between products and event admission based on the
proportionate average fair value of products and the allocated event admission.
The allocated event admission revenue contained in these pack sales are also
amortized over a twelve month period. Total deferred revenue was $433,000 and
$704,000 at December 31, 2001 and March 31, 2002, respectively.

Shipping and Handling Costs

The Company records freight and shipping revenues collected from
associates and members as revenue. The Company records in-bound freight and
shipping costs as a part of cost of sales and records shipping and handling
costs associated with shipping products to its associates and members as selling
and administrative expenses in the accompanying consolidated financial
statements. Total shipping and handling costs included in selling and
administrative expense were approximately $1.6 million and $1.4 million for the
three months ended March 31, 2001 and 2002, respectively.

Earnings Per Share

The Company calculates earnings (loss) per share pursuant to Statement
of Financial Accounting Standards No. 128, "Earnings Per Share" ("FAS 128"). FAS
128 requires dual presentation of basic and diluted earnings (loss) per share
("EPS") on the face of the Consolidated Statement of Operations for all entities
with complex capital structures and requires a reconciliation of the numerator
and denominator of the basic EPS computation to the numerator and denominator of
the diluted EPS computation. Basic EPS calculations are based on the
weighted-average number of common shares outstanding during the period, while
diluted EPS calculations are calculated using the weighted-average number of
common shares and dilutive common share equivalents outstanding during the
period. At March 31, 2001, all of the 3,228,685 common stock options and 213,333
warrants were excluded from the diluted EPS calculation and at March 31, 2002,
2,898,833 of the common stock options and 100,000 warrants were excluded from
the diluted EPS calculation, as their effect was antidilutive.

The following data shows the amounts used in computing earnings (loss)
per share and their effect on the weighted-average number of common shares of
dilutive common share equivalents for the three months ended March 31, 2001 and
2002. The amounts are rounded to the nearest thousand except for per share
amounts.

2001 2002
-------------------------------------- -------------------------------------
Loss Shares Per Share Income Shares Per Share
(Numerator) (Denominator) Amount (Numerator) (Denominator) Amount
----------- ------------- --------- ----------- ------------- ---------

Basic EPS:
Net income (loss) available to
common shareholders ($309) 24,799 ($0.01) $596 25,135 $0.02
Effect of dilutive securities:
Stock options - - - - 121 -
Warrants - - - - 13 -
----- ------ ------ ---- ------ -----
Diluted EPS:
Net income (loss) available to
common shareholders plus
assumed conversions ($309) 24,799 ($0.01) $596 25,269 $0.02
===== ====== ====== ==== ====== =====

NOTE 2 INVENTORIES

At December 31, 2001 and March 31, 2002 inventory, rounded to the
nearest thousands, consisted of the following:

2001 2002
---- ----
Raw materials............................ $ 4,311 $ 2,380
Finished goods........................... 4,075 3,557
------- -------
$ 8,386 $ 5,937
======= =======

NOTE 3 COMPREHENSIVE INCOME (LOSS)

Comprehensive income (loss) for the three months ended March 31, 2001
and 2002 is as follows (in thousands):

Three months ended March 31,
----------------------------
2001 2002
---- ----

Net income (loss).............................. ($309) $596
Foreign currency translation adjustment........ (234) (57)
----- ----
Comprehensive income (loss).................... ($543) $539
===== ====

NOTE 4 COMMITMENTS AND CONTINGENCIES

In September 2001, the Company amended its agreement with a high-level
associate and shareholder to promote the Company and develop downline growth in
Japan. The amendment further clarified that the Company would pay this associate
a royalty of $5.00 for each specific promotional item sold by the Company, up to
a maximum of $1.6 million. The Company began paying royalties associated with
this agreement in May 2002.

In January 2002, the Company began leasing approximately $250,000 of
computer hardware under a noncancelable master lease. The master lease contains
four separate three-year operating leases that expire at various times through
May 2005. In April 2002, the master lease was increased to $300,000. The master
lease requires the Company to restrict cash equal to 125% of the borrowed line
as collateral. At March 31, 2002, the Company restricted $300,000 of its cash
for use as collateral related to this master lease.

NOTE 5 RECENT ACCOUNTING PRONOUNCEMENTS

In July 2001, the Financial Accounting Standards Board issued Statements
of Financial Accounting Standards No. 141 ("SFAS 141") "Business Combinations"
and No. 142 ("SFAS 142") "Goodwill and Other Intangibles Assets."

SFAS 141 supercedes Accounting Principles Board Opinion No. 16 "Business
Combinations." The most significant changes made by SFAS 141 are that it
requires that the purchase method of accounting be used for all business
combinations initiated after June 30, 2001, establishes specific criteria for
recognition of certain intangible assets separately from goodwill and requires
the immediate write-off of unallocated negative goodwill.

SFAS 142 supercedes Accounting Principles Board Opinion No. 17
"Intangible Assets." SFAS 142 is effective for fiscal years beginning after
December 15, 2001. SFAS 142 prohibits goodwill and indefinite lived intangible
assets from being amortized and requires them to be annually tested for
impairment at each reporting unit level. In addition, SFAS 142 removes the
limitation of forty years for the useful lives of finite intangible assets.

In August 2001, the Financial Accounting Standards Board issued
Statements of Financial Accounting Standards No. 143 ("SFAS 143") "Accounting
for Asset Retirement Obligations" and in October 2001, issued No. 144 ("SFAS
144") "Accounting for the Impairment or Disposal of Long-Lived Assets."

SFAS 143 amends SFAS 19, "Financial Accounting and Reporting by Oil and
Gas Producing Companies" and is effective for fiscal years beginning after June
15, 2002. This statement requires that the fair value of a liability for an
asset retirement obligation be recognized in the period in which it is incurred
if a reasonable estimate of fair value can be determined. In addition, SFAS 143
requires the associated asset retirement costs to be capitalized as part of the
carrying amount of the long-lived asset.

SFAS 144 supercedes SFAS No. 121 "Accounting for the Impairment of
Long-Lived Assets and for Long-Lived Assets to be Disposed Of" and Accounting
Principles Board Opinion No. 30 "Reporting Results of Operations-Reporting the
Effects of Disposal of a Segment of a Business." SFAS 144 is effective for
fiscal years beginning after December 15, 2001. SFAS 144 requires that impaired
long-lived assets be measured at the lower of carrying amount or fair value less
costs to sell, regardless if they are reported in continuing operations or in
discontinued operations. In addition, discontinued operations should no longer
be measured at net realizable value or include amounts for operating losses that
have not yet occurred. Finally, SFAS 144 broadens the reporting of discontinued
operations to include all components of an entity with operations that can be
distinguished from the rest of the entity and that will be eliminated from the
ongoing operations of the entity in a disposal transaction.

In September 2001, the Emerging Issues Task Force ("EITF") issued EITF
01-09, "Accounting for Consideration Given by a Vendor to a Customer or Reseller
of the Vendor's Products," which addresses the statement of operations
characterization of stock option awards, royalties, and other cash consideration
the Company pays to its associates. The provisions of EITF 01-09 is effective
for fiscal years beginning after December 15, 2001.

The adoption of the above pronouncements as of January 1, 2002, had no
significant effect on its consolidated financial positions, results of
operations or cash flows.

Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations

The following discussion is intended to assist in the understanding of
Mannatech's financial position and its results of operations for the three
months ended March 31, 2002 compared to the same period in 2001. The
Consolidated Financial Statements and related Notes should be referred to in
conjunction with this discussion. Unless stated otherwise, all financial
information presented below, throughout this report and in the Consolidated
Financial Statements and related Notes includes Mannatech and all of its
subsidiaries on a consolidated basis.

Overview

Mannatech develops innovative, high-quality, proprietary nutritional
supplements, topical products and weight-management products that are sold
through a global network-marketing system throughout the United States, Canada,
Australia, the United Kingdom and Japan. Mannatech plans to begin distribution
of its products, for personal consumption, into New Zealand in the summer of
2002. The distribution of products into New Zealand will be serviced through
Mannatech's Australian subsidiary. Currently, Mannatech operates as a single
segment and primarily sells its products through a network of approximately
187,000 active associates and members as compared to 237,000 active associates a
year ago. Mannatech defines an "active associate" as an associate or member who
has purchased Mannatech products within the last twelve months.

Mannatech's net sales consist of sales from products sold, starter and
renewal packs sold and shipping fees. Substantially all product sales are made
to associates at published wholesale prices and are sold to members at a
discount from suggested retail pricing. Starter and renewal packs consist of
various combinations of products and promotional materials. Mannatech tries to
offer a comparable associate starter pack in each country in which it does
business; however, because each country has different regulatory guidelines that
must be followed, not all of Mannatech's packs are offered in all countries.
Mannatech defers the recognition of revenue for product sales until its
associates or members receive the products. During March 2001, Mannatech
increased the sale prices of certain of its products and shipping fees. In the
future, Mannatech believes its international operations may account for an
increasing percentage of consolidated net sales. The net sales by country as a
percentage of consolidated net sales are as follows:

United United
Three months ended March 31, States Canada Australia Kingdom Japan Total
--------------------------- ------ ------ --------- ------- ----- -----

2002....................... 77.5% 12.8% 3.6% 0.9% 5.2% 100.0%
2001....................... 78.4% 13.7% 3.3% 0.9% 3.7% 100.0%

For the three months ended March 31, 2002, net product and pack sales
increased in Australia and Japan. Mannatech believes this increase is in
response to leadership changes in its Australia and Japan operations and hiring
a new President of International Operations in December 2001. For its domestic
operations, net product sales decreased, but pack sales increased. Mannatech
believes its pack sales help indicate future product sales. Mannatech believes
the current decrease in net product sales of its domestic operation is due to
the following:

. a decrease in active associates;

. uncertain general economic conditions; and

. the change in the timing of its international annual
corporate-sponsored sales event, called Mannafest, which is used as
a recruiting tool by many of its associates. This event was held in
March 2001 and shifted to April 2002.

In June 2002, Mannatech plans to discontinue its MVP(TM) product, which
contains ephedrine. Net sales for MVP(TM) for the three months ended March 31,
2002 and 2001 were $269,000 and $377,000, respectively. In 2002, to help
stimulate net sales, Mannatech also plans to improve several of its core
products. Since March 2001, Mannatech introduced two new products and
reformulated some of its weight-management products. The new products include
the following:

. Glycentials(TM) Vitamin, Ambroglycin(TM) Mineral and Antioxidant
Formula, introduced in August 2001, a dietary supplement that helps
provide a balanced food matrix of vitamins, chelated minerals, trace
minerals, antioxidant co-factors and Ambrotose(R) complex;

. CardioBALANCE(TM) Heart Care Formula, introduced in October 2001, a
dietary supplement that helps provide a wide range of specific
nutritional benefits designed to aid in keeping an already healthy
cardiovascular system strong and well; and

. GlycoLEAN(R) Body System, reformulated and introduced in January
2002 that includes a full spectrum of various weight management
products, new and updated comprehensive information, charts, better
tasting meal replacement drinks and a reformulated GlycoLEAN(R)
Accelerator2(TM), which includes a new ephedrine-free ingredient.

Costs of sales primarily consist of cost of products purchased from
third-party manufacturers, costs of promotional materials sold to Mannatech's
associates and write-downs of inventory. As the mix of products, packs and
promotional material shifts, costs of sales and gross profit may fluctuate due
to the different margins on each product sold.

Mannatech's most significant expense is commissions. When Mannatech
expanded internationally, it integrated the majority of its associate's global
incentive plan across all markets in which its products were sold, thereby
allowing all of its existing associates to receive commissions for direct and
indirect global product sales. This global structure allows associates to build
their global networks by expanding their existing downlines into newly-formed
international markets rather than having to establish new downlines to requalify
for higher levels of commissions within each new country. Mannatech pays its
associates various commissions and incentives based upon the associates' direct
and indirect product sales and expansion of their downlines.

In late 2001, Mannatech outlined its overall plans to change its global
associate incentive plan to eliminate a commission that is paid only in the
United States and Canada that rewards associates for building their network and
increases the payouts of all other existing commissions paid in order to
concentrate commission payments on product sales and network development.
Generally, commissions and incentives are paid to associates based on the
following:

. associates' placement and position within the incentive plan;

. volume of their direct and indirect commissionable sales;

. number of newly-enrolled associates; and

. achievement of certain levels to qualify for the various incentive
programs.

Operating expenses consist primarily of selling and administrative
expenses and other operating costs. Selling and administrative expenses are a
combination of both fixed and variable expenses and include compensation,
shipping and freight and marketing-related expenses such as hosting Mannatech's
national corporate-sponsored events. Other operating costs include utilities,
depreciation, travel, consulting fees, professional fees, office expenses,
printing expenses and miscellaneous operating expenses.

Income taxes include both domestic and foreign taxes. In 2001 and 2002,
Mannatech's United States federal statutory tax rate was 34%. Mannatech pays
taxes in Australia at a statutory tax rate of approximately 36% and in the
United Kingdom at a statutory tax rate of approximately 30%. Mannatech expects
to pay taxes in Japan at a statutory tax rate ranging between 42% and 48%;
however, since its inception, Mannatech has only reported net operating losses
in Japan. Mannatech also pays taxes in various state jurisdictions at an
approximate average effective tax rate of 3%. Due to its international
operations, a portion of Mannatech's income is subject to taxation in the
countries in which it operates; however, it may receive foreign tax credits that
would reduce the amount of United States taxes owed. Mannatech may not be able
to use all of such foreign tax credits in the United States. Mannatech may also
incur net operating losses that may not be fully realizable. Mannatech records a
valuation allowance for any expected net operating losses, which it may not be
able to realize in the future.

Results of Operations

The following table summarizes Mannatech's operating results as a
percentage of net sales for each of the periods indicated.

Three months ended
March 31,
------------------
2001 2002
---- ----

Net sales ........................................ 100.0% 100.0%
Cost of sales .................................... 16.8 17.9
Commissions ...................................... 40.4 42.0
------ ------
Gross profit .............................. 42.8 40.1
Operating expenses:
Selling and administrative expenses ......... 26.4 22.8
Other operating costs ....................... 17.9 13.7
------ ------
Income (loss) from operations ............. (1.5) 3.6
Interest income .................................. 0.3 0.2
Interest expense ................................. (0.0) 0.0
Other expense, net ............................... (0.3) (0.1)
------ ------
Income (loss) before income taxes ......... (1.5) 3.7
Income tax (expense) benefit ..................... 0.6 (1.9)
------ ------
Net income (loss) ......................... (0.9)% 1.8%
====== ======
Number of starter packs sold ..................... 16,582 18,653
Number of renewal packs sold ..................... 13,986 11,971
------ ------
Total number of packs sold ....................... 30,568 30,624
====== ======
Total associates canceling associate status ...... 1,217 1,158
====== ======

Three months ended March 31, 2002 compared with the three months ended March 31,
2001

Net sales. Net sales decreased (3.8%) to $32.9 million for the three
months ended March 31, 2002 from $34.2 million for the comparable period in
2001. Net sales consist of both product sales and pack sales. The decrease in
net sales consisted of the following:

. the change in timing of Mannafest from March 2001 to April 2002;

. a ($2.3) million decrease in product sales, which primarily related
to an overall decrease of active associates by (21.1%) as compared
to the comparable period in 2001. This decrease was partially offset
by the introduction of Mannatech's new products: Glycentials(TM)
Vitamin, Ambroglycin(TM) Mineral and Antioxidant Formula and
CardioBALANCE(TM); and

. a $1.0 million increase in pack sales, which primarily related to
the completion of a successful travel incentive for its associates
to win a cruise. Mannatech will continue to offer periodic travel
incentives in the future. Mannatech believes that its pack sales
help predict the expected change in active associates and are a
leading indicator of future product sales.

Cost of sales. Cost of sales increased 3.5% to $5.9 million for the
three months ended March 31, 2002 from $5.7 million for the comparable period in
2001. As a percentage of net sales, cost of sales increased to 17.9% for the
three months ended March 31, 2002 from 16.8% for the comparable period in 2001.
The percentage increase in cost of sales as a percentage of net sales was
primarily due to the following:

. a higher raw material ingredient costs;

. the introduction of the free product with the enrollment of an
automatic order; and

. the change in the mix of finished goods sold.

Commissions. Commissions remained at $13.8 million for the three months
ended March 31, 2002 and for the comparable period in 2001. As a percentage of
net sales, commissions increased to 42.0% for the three months ended March 31,
2002 from 40.4% for the comparable period in 2001. The increase was the result
of introducing new incentive programs for its associates.

Gross profit. Gross profit decreased (10.2%) to $13.2 million for the
three months ended March 31, 2002 from $14.7 million for the comparable period
in 2001. As a percentage of net sales, gross profit decreased to 40.1% for the
three months ended March 31, 2002 from 42.8% for the comparable period in 2001.
These changes were primarily attributable to the change in mix of sales and the
increase in commissions as a result of introducing additional incentive programs
for its associates.

Selling and administrative expenses. Selling and administrative expenses
decreased (16.7%) to $7.5 million for the three months ended March 31, 2002 from
$9.0 million for the comparable period in 2001. As a percentage of net sales,
selling and administrative expenses decreased to 22.8% for the three months
ended March 31, 2002 from 26.4% for the comparable period in 2001. The decrease
was primarily due to the following:

. a ($250,000) decrease in compensation, including wages and payroll
benefits related to the termination of various highly-paid
executives during 2001, partially offset by the increase in
compensation related to the replacement of some of these executives
and establishing in-house order processing and customer service
centers in each of its foreign operations, except for Canada;

. a $119,000 increase in contract labor related to the increase in the
number of programmers needed for the expected on-going maintenance
to the global incentive plan;

. a ($224,000) decrease in freight costs related to the decrease in
net sales;

. a ($1.1) million decrease in expenses related to the timing of
Mannafest; and

. the remaining decrease related to a decrease in various marketing
expenses.

Other operating costs. Other operating costs decreased (26.2%) to $4.5
million for the three months ended March 31, 2002 from $6.1 million for the
comparable period in 2001. As a percentage of net sales, other operating costs
decreased to 13.7% for the three months ended March 31, 2002 from 17.9% for the
comparable period in 2001. The dollar decrease was primarily due to the
following:

. a ($799,000) decrease related to canceling various contracts with
third-party contractors to provide its international operations with
order processing and customer service;

. a ($318,000) decrease in travel expenses primarily related to
minimizing travel to its international operations;

. a ($396,000) decrease in accounting, legal and consulting services,
which are no longer needed for international operations and the
cancellation of various consulting contracts related to its
international operations; and

. the remaining decrease related to the decrease in various operating
expenses.

Interest income. Interest income decreased (23.7%) to $74,000 for the
three months ended March 31, 2002 from $97,000 for the comparable period in
2001. As a percentage of net sales, interest income decreased to 0.2% for the
three months ended March 31, 2002 from 0.3% for the comparable period in 2001.
The decrease was primarily due to the decrease in interest rates.

Interest expense. Interest expense decreased (33.3%) to $6,000 for the
three months ended March 31, 2002 from $9,000 for the comparable period in 2001.
As a percentage of net sales, interest expense remained at 0.0% for the three
months ended March 31, 2002 and for the comparable period in 2001. The dollar
decrease was primarily due

to the repayment of existing capital leases and notes payable, partially offset
by refinancing the renewal of its annual insurance premiums for 2002.

Other income (expense), net. Other income (expense), net consists
primarily of foreign currency translation adjustments related to Mannatech's
foreign operations. Other income (expense), net decreased (85.2%) to $17,000 for
the three months ended March 31, 2002 from $115,000 for the comparable period in
2001. As a percentage of net sales, other income (expense), net decreased to
0.1% for the three months ended March 31, 2002 from 0.3% for the comparable
period in 2001. The decrease was the result of fluctuations in the currency
exchange rates.

Income tax (expense) benefit. Income tax (expense) benefit increased to
$619,000 for the three months ended March 31, 2002 from ($212,000) for the
comparable period in 2001. Mannatech's effective tax rate increased to 50.9% for
the three months ended March 31, 2002 from 40.6% for the comparable period in
2001. Mannatech's effective tax rate increased primarily as a result of
increasing the valuation allowance for the net operating losses from its Japan
subsidiary.

Net income (loss). Net income (loss) increased to $596,000 for the three
months ended March 31, 2002 from ($309,000) for the comparable period in 2001.
As a percentage of net sales, net income (loss) increased to 1.8% for the three
months ended March 31, 2002 from (0.9%) for the comparable period in 2001.
Mannatech reported diluted earnings per share of $0.02 for the three-months
ended March 31, 2002 as compared to a loss per share of ($0.01) for the
comparable period in 2001. The dollar increase was primarily the result of
reducing certain fixed operating expenses, partially offset by the decrease in
gross profit related to the decrease in product sales and the introduction of
additional incentives for Mannatech's associates.

Liquidity and Capital Resources

Historically, Mannatech has funded its business objectives, working
capital and operations primarily through its cash flows from operations.

Working capital. Mannatech's working capital increased from $5.9 million
at December 31, 2001 to $6.7 million as of March 31, 2002. In 2001, Mannatech
funded $1.8 million in severance payments to various former executives and
concentrated on reducing its inventories. In 2002, Mannatech increased cash on
hand by curtailing certain operating expenses, which was partially offset by
funding the various severance payments to its former executives as set forth in
their separation agreements. Mannatech believes it can continue to fund its
business objectives, working capital and operations primarily through its cash
flows from operations.

Mannatech's cash flow are as follows:

For the three months ended March 31,
------------------------------------

Provided by (used in): 2002 2001
----------------------- ---- ----

Operating activities................... $3.4 million ($400,000)
Investing activities................... ($538,000) $ 73,000
Financing activities................... ($ 32,000) ($1.6 million)

Operating activities. For the three months ended March 31, 2001,
operating activities consisted of a decrease in cash, primarily due to a $1.1
million decrease in accounts payable and accrued expenses offset by $700,000
from earnings before depreciation and amortization. For the three months ended
March 31, 2002, operating activities consisted of an increase in cash, primarily
due to $1.6 million from earnings before depreciation and amortization and an
increase of $1.8 million from the net change in working capital. The net change
in working capital was primarily the result of a $2.4 million decrease in
inventory.

Investing activities. For the three months ended March 31, 2001,
investing activities consisted of the $143,000 repayment of notes receivable due
from certain shareholders/affiliates, partially offset by capital asset
purchases of ($73,000) related to computer hardware and software. For the three
months ended March 31, 2002, investing activities consisted of ($288,000) in
capital asset additions related to computer hardware and software and
restricting ($300,000) in cash as collateral related to the master operating
lease. The decrease in the repayment of notes receivable due from shareholders
was the result of Mr. Gary Watson and Mr. William C. Fioretti, former officers
and shareholders not paying their payments related to their notes receivable,
including interest, of approximately $67,000. As of May 8, 2002, the remaining
balance owed to Mannatech by these two shareholders was $164,680.

Financing activities. For the three months ended March 31, 2001,
financing activities consisted of the repayment of book overdrafts of ($1.4)
million, repayment of capital leases and notes payable of ($162,000) and the
repayment of a note receivable related to Mr. Charles E. Fioretti of ($83,333)
as set forth in the repurchase agreement with Mr. Fioretti, which was terminated
in September 2001. For the three months ended March 31, 2002, financing
activities consisted of the repayment of capital leases and notes payable.

Mannatech believes that its existing liquidity and cash flows from
operations, including current cash on hand of $12.7 million, capital resources
and finance company's borrowings, including an operating lease line-of-credit
totaling $300,000, together with the continued suspension of dividend payments
to shareholders, should be adequate to fund its business operations and
commitments for the next twelve months. However, if existing capital resources
or cash flows become insufficient to meet Mannatech's business plans and
existing capital requirements, Mannatech would be required to raise additional
funds, which it cannot assure will be available on favorable terms, if at all.
Mannatech's existing commitments and obligations include the following:

. funding payments totaling $2.2 million related to the resignations
of former executives in 2001. Under the terms of the various
separation agreements, Mannatech is required to pay the remaining
aggregate amount of $2.2 million, of which $1.6 million will be paid
over the next twelve months.

. funding the remaining payments of its annual insurance premiums,
totaling approximately $300,000, which were financed with a finance
company and are due in monthly installments through July 2002.

. funding various marketing promotional incentives estimated at $2.7
million.

. a purchase commitment with its supplier of Manapol(R), one of the
key ingredients used in Mannatech's proprietary
compound--Ambrotose(R) complex. The purchase commitment requires
Mannatech to purchase $3.7 million in 2002 and $2.5 million in 2003
of Manapol(R).

The approximate future maturities of notes payable, capital leases,
severance payments to executives, purchase commitment and minimum rental
commitments related to various non-cancelable operating leases are as follows
(in thousands):

For the nine months
ended December 31, For the year ended December 31,
------------------ ----------------------------------------------
2002 2003 2004 2005 2006 Thereafter
---- ---- ---- ---- ---- ----------

Notes payable and financing ................................... $ 272 $ -- $ -- $ -- $ -- $ --
Capital leases ................................................ 29 8 7 -- -- --
Severance payments to former executives ....................... 1,621 475 150 -- -- --
Purchase commitment ........................................... 2,755 2,450 -- -- -- --
Minimum rental commitment related to noncancellable
operating leases ............................................ 1,362 1,021 808 745 738 303
------ ------ ------ ------ ----- -----
$6,039 $3,954 $ 965 $ 745 $ 738 $ 303
====== ====== ====== ====== ===== =====

Mannatech has no present commitments or agreements with respect to any
acquisitions or purchases of any manufacturing facilities. Mannatech believes
any unanticipated future changes in its operations could consume available
capital resources faster than anticipated. Mannatech also believes that its
existing capital requirements depend on its ability to refine and introduce
high-quality products, to attract new associates and to retain and expand its
current associates and members.

During 2001, Mannatech entered into various financing agreements to
finance insurance premiums totaling $0.8 million. The notes required a 25% down
payment, accrue interest at 9.15% and are due in eight monthly payments through
July 2002. In January 2002, Mannatech entered into a three-year capital lease to
lease warehouse equipment of $32,500.

Recent Financial Accounting Standards Board Statements

In September 2001, the Emerging Issues Task Force ("EITF") issued EITF
01-09, "Accounting for Consideration Given by a Vendor to a Customer or Reseller
of the Vendor's Products," which addresses the statement of operations
characterization of stock option awards, royalties, and other cash consideration
Mannatech pays its associates. The provisions of EITF 01-09 is effective for
fiscal years beginning after December 15, 2001.

The adoption of the above pronouncements as of January 1, 2002, had no
significant effect on its consolidated financial positions, results of
operations or cash flows.

Outlook

Mannatech believes its outlook for the remainder of 2002 will be
contingent upon the success of retaining and expanding its active associates and
members, its ability to refine and introduce new high-quality products that will
increase sales and effectively communicating the changes to its compensation
plan. Mannatech believes its increase of $1.0 million in net pack sales for the
three months ended March 31, 2002 as compared to the comparable period in 2001,
is an indication of future product sales.

Forward-Looking Statements

Certain disclosure and analysis included under "Management's Discussion
and Analysis of Financial Condition and Results of Operations," "Quantitative
and Qualitative Disclosures about Market Risk," "Other Information" and Notes to
Consolidated Financial Statements and elsewhere in this report includes
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, Section 21E of the Securities Exchange Act of 1934 and
the Private Securities Litigation Reform Act of 1995 and are subject to various
risks and uncertainties. Opinions, forecasts, projections, guidance or other
statements other than statements of historical fact are considered
forward-looking statements and reflects the current view of Mannatech about
future events and financial performance. These forward-looking statements are
subject to certain events, risks and uncertainties that may be outside
Mannatech's control. Some of these forward-looking statements include statements
regarding:

. existing cash flows being adequate to fund future cash needs;

. management's plans, objectives for its future operations and
economic performance;

. the realization of deferred tax assets;

. the ability to maintain current levels of operating expenditures;

. the impact of future market changes due to its exposure to foreign
currency translations;

. any significant impact on its financial positions, results of
operations or cash flows by recent accounting pronouncements;

. the outcome of regulatory and litigation matters;

. the global statutory tax rates remaining unchanged;

. the establishment of certain policies, procedures and internal
processes to combat exposure to market risk; and

. the assumptions described in this report underlying such
forward-looking statements.

Actual results and developments may materially differ from those
expressed in or implied by such statements due to a number of factors,
including:

. those described in the context of such forward-looking statements;

. future product development and manufacturing costs;

. the impact of any changes to Mannatech's global incentive plans;

. the retention and expansion of Mannatech's associate and member
base;

. its pack sales being a leading indicator of product sales for the
next twelve months;

. timely development and acceptance of new products or refinements of
existing products;

. the markets for Mannatech's domestic and international operations;

. the impact of new competition and competitive products and pricing;

. the political, social and economic climate in which Mannatech
conducts its operations; and

. the risk factors described in other documents and reports filed with
the Securities and Exchange Commission.

In some cases, forward-looking statements are identified by terminology
such as "may," "will," "should," "could," "expects," "plans," "intends,"
"anticipates," "believes," "estimates," "approximates," "predicts," "potential,"
"projects." "in the future" or "continue" or the negative of such terms and
other comparable terminology. Readers are cautioned when considering these
forward-looking statements to keep in mind these risks and uncertainties and any
other cautionary statements in this report as all of the forward-looking
statements contained herein speak only as of the date of this report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Mannatech does not engage in trading market risk sensitive instruments
and does not purchase as investments, as hedges or for purposes "other than
trading," instruments that are likely to expose it to certain types of market
risk, including interest rate, commodity price or equity price risk. Although
Mannatech has investments, there has not been any material change in its
exposure to interest rate risk. Mannatech has not issued any debt instruments,
entered into any forward or futures contracts, purchased any options or entered
into any swaps.

Mannatech is exposed to certain other market risks, including changes in
currency exchange rates as measured against the United States dollar. The value
of the United States dollar may affect Mannatech's financial results. Changes in
exchange rates may positively or negatively affect its financial results, as
expressed in United States dollars. When the United States dollar increases
against currencies in which products are sold or there is a weakening exchange
rate against currencies in which Mannatech incurs costs, net sales or costs may
be adversely affected.

Mannatech has established policies, procedures and internal processes,
which it believes will help monitor any significant market risks. Currently,
Mannatech does not use any financial instruments to manage its exposure to such
risks. The sensitivity of earnings and cash flows to variability in currency
exchange rates is assessed by applying an appropriate range of potential rate
fluctuations to Mannatech's assets, obligations and projected transactions
denominated in foreign currency. Mannatech cannot predict with any certainty its
future exposure to such currency exchange rate fluctuations or the impact, if
any, such fluctuations may have on its future business, product pricing,
consolidated financial position, results of operations or cash flows. However,
Mannatech believes it closely monitors current fluctuations for exposure to such
market risk. Currently, the foreign currencies in which Mannatech has exposure
to foreign currency exchange rate risk include Canada, Australia, the United
Kingdom and Japan. The high and low currency exchange rates to the United States
dollar, for each of these countries, for the three-months ended March 31, 2002
are as follows:

Country/Currency High Low
---------------- -------- --------
Canadian/Dollar.................... $0.63550 $0.61750
Australia/Dollar................... $0.53550 $0.50490
United Kingdom/British Pound....... $1.45690 $1.40380
Japan/Yen.......................... $0.00791 $0.00739

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

There have been no material changes in, or additions to, the legal
proceedings previously reported in Mannatech's Annual Report on Form 10-K as
amended (File No. 000-24657) for 2001 as filed with the Securities and Exchange
Commission on April 1, 2002.

Item 2. Changes in Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Submission of Matters to a Vote of Security Holders

None.

Item 5. Other Information

On March 5, 2002, the Board of Directors nominated Mr. Samuel L. Caster
as Chairman of the Board and Mr. Jules Zimmerman as Vice-Chairman of the Board.
Mr. James M. Doyle Jr. and Dr. Steven A. Barker Ph.D., whose terms as directors
expire on June 4, 2002, announced that they do not intend to stand for
re-election to the Board, effective June 4, 2002.

Item 6. Exhibits and Reports on Form 8-K

(a) Exhibits required by Item 601 of Regulation S-K

3.1 Amended and Restated Articles of Incorporation of Mannatech dated May
19, 1998, incorporated herein by reference to Exhibit 3.1 to
Mannatech's Form S-1 (File No. 333-63133) filed with the Commission on
October 28, 1998.

3.2 Fourth Amended and Restated Bylaws of Mannatech dated April 27, 2001,
incorporated herein by reference to Exhibit 99.1 to Mannatech's Form
8-K (File No. 000-24657) filed with the Commission on August 22, 2001.

4.1 Specimen Certificate representing Mannatech's common stock, par value
$0.0001 per share, incorporated herein by reference to Exhibit 4.1 to
Mannatech's Amendment No. 1 to Form S-1 (File No. 333-63133) filed with
the Commission on October 28, 1998.

(b) Reports on Form 8-K.

None.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

MANNATECH, INCORPORATED

May 15, 2002 /S/ ROBERT M. HENRY
-----------------------------------------
Robert M. Henry
Chief Executive Officer and Director
(principal executive officer)

May 15, 2002 /S/ STEPHEN D. FENSTERMACHER
-----------------------------------------
Stephen D. Fenstermacher
Senior Vice President and
Chief Financial Officer
(principal financial officer)

INDEX TO EXHIBITS